The US FDA has granted Orphan Drug status to Zai Lab's (LAB) antibody-drug conjugate zocilurtatug pelitecan for neuroendocrine carcinomas. - The asset previously received Fast Track designation for other indications, including small cell lung cancer. - Zoci targets Delta-like...<
The US FDA has granted Orphan Drug status to Zai Lab’s (LAB) antibody-drug conjugate zocilurtatug pelitecan for neuroendocrine carcinomas. – The asset previously received Fast Track designation for other indications, including small cell lung cancer. – Zoci targets Delta-like…
gand 3 (DLL3), which is overexpressed in many neuroendocrine carcinomas
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
